Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Hydroxyzine MeSH Descriptor Data 2026


MeSH Heading
Hydroxyzine
Tree Number(s)
D03.383.606.515
Unique ID
D006919
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006919
Scope Note
A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
Entry Term(s)
2-(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)ethanol
Atarax
Durrax
Hydroxyzine Dihydrochloride
Hydroxyzine Hydrochloride
Hydroxyzine Pamoate
Orgatrax
Vistaril
Pharm Action
Antipruritics
Histamine H1 Antagonists
Registry Numbers
30S50YM8OG
0
76755771U3
M20215MUFR
2192-20-3
Related Numbers
10246-75-0
2192-20-3
68-88-2
76755771U3
M20215MUFR
CAS Type 1 Name
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-
Date Introduced
1966/01/01
Last Updated
2016/05/31
Hydroxyzine Preferred
Orgatrax Narrower
Vistaril Narrower
Hydroxyzine Hydrochloride Narrower
Atarax Narrower
Hydroxyzine Pamoate Narrower
Hydroxyzine Dihydrochloride Narrower
Durrax Narrower
page delivered in 0.176s